Infection and inflammation induce LDL oxidation in vivo

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 6, 2000, Pages 1536-1542

  Memon, Riaz A ^a,b   Staprans, Ilona ^a   Noor, Mustafa ^a,b   Holleran, Walter M ^a   Uchida, Yoshikazu ^a   Moser, Arthur H ^a,b   Feingold, Kenneth R ^a,b   Grunfeld, Carl ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Infection; Inflammation; Lipoproteins

Indexed keywords

ALKADIENE; BACTERIUM LIPOPOLYSACCHARIDE; LIPID HYDROPEROXIDE; LYSOPHOSPHATIDYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TURPENTINE; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; INCIDENCE; INFECTION; INFLAMMATION; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; SYRIAN HAMSTER;

EID: 0034041239     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.6.1536     Document Type: Article

References (52)

1. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levy J, Tossey T, Camm AJ, Northfield TC. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 1995;30:121-128.
2. Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis Eur Heart J. 1993;14(suppl K):3-38.
3. Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of carotid artery. Circulation. 1997;96:2144-2148.
4. Mendall MA, Goggin PM, Molineaux N, Levy J, Tossey T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylon infection and coronary heart disease. Br Heart J. 1994;71:437-439.
5. Mattila KJ, Valtonen VV, Nieminen M, Huttunen JK. Dental infections and the risk of new coronary events: prospective study of patients with documented coronary artery disease. Clin Infect Dis. 1995;20:588-592.
6. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 1996;348:567-572.
7. Myllykangas-luosujarvi R, Aho K, Kautiainen H, Isomaki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol. 1995; 22:1065-1067.
8. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol. 1978;99:469-475.
9. Gabay C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Eng J Med. 1999;340:448-454.
10. Cabana VG, Siegel JN, Sabesin SM. Effect of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res. 1989;30:39-49.
11. Feingold KR, Staprans I, Memon RA, Moser AH, Shigenaga JK, Doerrler W, Dinarello CA, Grunfeld C. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res. 1992;33:1765-1776.
12. Feingold KR, Hardardottir I, Memon RA, Krul EJT, Moser AH, Taylor JM, Grunfeld C. The effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res. 1993; 34:2147-2158.
13. Feingold KR, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C. The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab. 1993;76:1423-1427.
14. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20:707-727.
15. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
16. Staprans I, Rapp JL, Pan X-M, Hardman DA, Feingold KR. Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 1996;16:533-538.
17. Staprans I, Pan X-M, Rapp JL, Feingold KR. Oxidized cholesterol in the diet accelerates the development of aortic atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vase Biol. 1998;18:977-983.
18. Mackness MI, Mackness B, Durrington PN, Connelly PW, Hegele RA. Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol. 1996;7:69-76.
19. Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995;96:2758-2767.
20. Feingold KR, Memon RA, Moser AH, Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis. 1998;139:307-315.
21. Rao TS, Currie JL, Shaffer AF, Isakson PC. In vivo charactenzation of zymosan-induced mouse peritoneal inflammation. J Pharmacol Exp Ther. 1994;269:917-925.
22. Todd NJ, Whicher JT, Westacott C, Gilbert A. The acute phase response in mice does not show tolerance to recurrent sterile inflammation. Clin Chim Acta. 1990;189:47-54.
23. Spady DK, Dietschy JM. Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. J Clin Invest. 1988;81:300-309.
24. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
25. Corongiu FP, Banni S. Detection of conjugated dienes by second derivative ultraviolet spectrophotometry. Methods Enzymol. 1994;233: 303-310.
26. Staprans I, Rapp JH, Pan X-M, Kim KY, Feingold KR. Oxidized lipids in the diet are a source of oxidized lipids in chylomicrons of human serum. Arterioscler Thromb. 1994;14:1900-1905.
27. Ohishi N, Ohkawa H, Mike A, Tatano T, Yagi K. A new assay method for lipid peroxides using a methylene blue derivative. Biochem Int. 1985;10:205-211.
28. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res. 1983; 24:1070-1076.
29. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci USA. 1988;85:2805-2809.
30. Bartlett G. Phosphorus assay in column chromatography. J Biol Chem. 1959;234:446-448.
31. Esterbauer H, Striegel G, Puhl H, Rotheneger M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res. 1989;6:67-75.
32. Steinbrecher UP, Pritchard PH. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J Lipid Res. 1989;30:305-315.
33. Memon RA, Fuller J, Moser AH, Feingold KR, Grunfeld C. In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. Am J Physiol. 1999;277:R94-R103.
34. Frei B. Cardiovascular disease and nutrient anti-oxidants: role of low density lipoprotein oxidation. Crit Rev Food Sci Nutr. 1995;35:83-98.
35. Suarna C, Dean RT, May J, Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate. Arterioscler Thromb Vase Biol. 1995;15:1616-1624.
36. Castellani LW, Navab M, Van Lenten BJ, Hedrick CC, Hama SY, Goto AM, Fogelman AM, Lusis AJ. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles. J Clin Invest. 1997;100:464-474.
37. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high density lipoprotein oxidation and preserves its function: a possible peroxidative role for paraoxonase. J Clin Invest. 1998;101:1581-1590.
38. Shih DM, Gu L, Xia Y, Navab M, Li W, Hama S, Castellani LW, Furlong CE, Costa LG, Fogelman AM, Lusis AJ. Mice lacking paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 1998;394:284-287.
39. Gitlin JD. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J Biol Chem. 1988;263:6281-6287.
40. Chisolm GM, Hazen SL, Fox PL, Cathcart MK. The oxidation of lipoproteins by monocytes and macrophages. J Biol Chem. 1999;274: 25959-25962.
41. Kunitake ST, Jarvis MR, Hamilton RI, Kane JP. Binding of transition metals by apolipoprotein A-1 containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci U S A. 1992;89:6993-6997.
42. Barnum-Huckins KM, Martinez AO, Rivera EV, Adrian EK Jr, Herbert DC, Weaker FJ, Walter CA, Adrian GS. A comparison of suppression of human transferrin synthesis by lead and lipopolysaccharide. Toxicology. 1997;118:11-22.
43. Khovidhunkit W, Memon RA, Shigenaga JK, Pang M, Schambelan M, Mulligan K, Feingold KR, Grunfeld C. Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism. 1999;48: 1524-1531.
44. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis. In press.
45. Hoffman JS, Benditt EP. Changes in high density lipoprotein content following endotoxin administration in the mouse: formation of serum amyloid protein-rich subfractions. J Biol Chem. 1982;257:10510-10517.
46. Khoo JC, Miller E, McLoughlin P, Steinberg D. Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-I. J Lipid Res. 1990;31:645-652.
47. Memon RA, Holleran WM, Moser AH, Seki T, Uchida Y, Fuller J, Shigenaga JK, Grunfeld C, Feingold KR. Endotoxin and cytokines increase hepatic sphingolipid biosynthesis and produce lipoproteins enriched in ceramides and sphingomyelin. Arterioscler Thromb Vasc Biol. 1998;18:1257-1265.
48. Schissel S, Tweedie-Hardman J, Rapp JL, Graham G, Williams K, Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low density lipoprotein: proposed role for arterial wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest. 1996;98:1455-1464.
49. Grisham MB, Everse J, Janssen HF. Endotoxemia and neutrophil activation in vivo. Am J Physiol. 1988;254:H1017-H1012.
50. Heinecke JW. Mechanisms of oxidative damage of low-density lipoprotein in human atherosclerosis. Curr Opin Lipidol. 1997;8: 268-274.
51. Schade UF. Involvement of lipoxygenases in the activation of mouse macrophages by endotoxin. Biochem Biophys Res Commun. 1986;138: 842-849.
52. Folcik VA, Nivar-Aristy RA, Krajewski LP, Cathcart MK. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J Clin Invest. 1995;96:504-510.